These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8389960)

  • 1. The ovine corticotropin-releasing hormone-stimulation test in type I diabetic patients and controls: suggestion of mild chronic hypercortisolism.
    Roy MS; Roy A; Gallucci WT; Collier B; Young K; Kamilaris TC; Chrousos GP
    Metabolism; 1993 Jun; 42(6):696-700. PubMed ID: 8389960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
    Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F
    Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal cortisol secretion and responses to corticotropin-releasing hormone in women with hypothalamic amenorrhea.
    Biller BM; Federoff HJ; Koenig JI; Klibanski A
    J Clin Endocrinol Metab; 1990 Feb; 70(2):311-7. PubMed ID: 2153693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose ovine corticotropin-releasing hormone stimulation test in diabetes mellitus with or without neuropathy.
    Coiro V; Volpi R; Capretti L; Speroni G; Caffarra P; Scaglioni A; Malvezzi L; Castelli A; Caffarri G; Rossi G
    Metabolism; 1995 Apr; 44(4):538-42. PubMed ID: 7723679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of carbamazepine on pituitary-adrenal function in healthy volunteers.
    Perini GI; Devinsky O; Hauser P; Gallucci WT; Theodore WH; Chrousos GP; Gold PW; Kling MA
    J Clin Endocrinol Metab; 1992 Feb; 74(2):406-12. PubMed ID: 1309836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol before and after weight loss.
    Yanovski JA; Yanovski SZ; Gold PW; Chrousos GP
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1874-8. PubMed ID: 9177399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW; Kling MA; Khan I; Calabrese JR; Kalogeras K; Post RM; Avgerinos PC; Loriaux DL; Chrousos GP
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovine corticotropin-releasing hormone stimulation test in normal children.
    Ross JL; Schulte HM; Gallucci WT; Cutler GB; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1986 Feb; 62(2):390-2. PubMed ID: 3001126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
    Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
    J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin releasing hormone stimulation test and nocturnal cortisol levels in normal children.
    Dahl RE; Siegel SF; Williamson DE; Lee PA; Perel J; Birmaher B; Ryan ND
    Pediatr Res; 1992 Jul; 32(1):64-8. PubMed ID: 1321974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of adrenocorticotropin (ACTH) stimulation tests and insulin hypoglycemia in normal humans: low dose, standard high dose, and 8-hour ACTH-(1-24) infusion tests.
    Nye EJ; Grice JE; Hockings GI; Strakosch CR; Crosbie GV; Walters MM; Jackson RV
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3648-55. PubMed ID: 10523009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovine corticotropin-releasing hormone stimulation test in patients with chronic renal failure: pharmacokinetic properties, and plasma adrenocorticotropic hormone and serum cortisol responses.
    Siamopoulos KC; Eleftheriades EG; Pappas M; Sferopoulos G; Tsolas O
    Horm Res; 1988; 30(1):17-21. PubMed ID: 2851525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone.
    Reincke M; Allolio B; Würth G; Winkelmann W
    J Clin Endocrinol Metab; 1993 Jul; 77(1):151-6. PubMed ID: 8392081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothalamic pituitary adrenal function in the extremely low birth weight infant.
    Hanna CE; Keith LD; Colasurdo MA; Buffkin DC; Laird MR; Mandel SH; Cook DM; LaFranchi SH; Reynolds JW
    J Clin Endocrinol Metab; 1993 Feb; 76(2):384-7. PubMed ID: 8381799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis.
    Crofford LJ; Kalogeras KT; Mastorakos G; Magiakou MA; Wells J; Kanik KS; Gold PW; Chrousos GP; Wilder RL
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1279-83. PubMed ID: 9100607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.